Document is current
Any future updates will be listed below
-
Authors
Penack, Olaf https://orcid.org/0000-0003-4876-802X
Bacigalupo, Andrea
Gavriilaki, Eleni https://orcid.org/0000-0002-8883-8208
Greinix, Hildegard
Malard, Florent https://orcid.org/0000-0002-3474-0002
Michonneau, David https://orcid.org/0000-0003-4553-3065
Olivieri, Attilio https://orcid.org/0000-0001-9089-9328
Peric, Zinaida
Sala, Elisa
Solano, Carlos https://orcid.org/0000-0003-3702-0817
Wolff, Daniel https://orcid.org/0000-0001-7015-3190
Zeiser, Robert https://orcid.org/0000-0001-6565-3393
-
Funding
Funding for this research was provided by:
Therakos, a Mallinckrodt Pharmaceuticals Company
- License Information
-
More Information
Article History
Received: 21 August 2024
Revised: 9 June 2025
Accepted: 14 July 2025
First Online: 22 July 2025
Competing interests
: This study was sponsored by Therakos UK Limited (Staines, United Kingdom). Authors (FM, DM, CS, RZ, DW, ES, HG, ZP, EG, AB, AO) received an honorarium from Therakos for their participation in the Delphi panel. OP did not participate in the Delphi panel study but has received an honorarium from Therakos for his involvement in this project which included the development of the Delphi questionnaire, analysis of data and editing of the manuscript.
